Obesity and Peripheral Artery Disease: Current Evidence and Controversies.

Authors:
Lempesis IG; Varrias D; Sagris M; Attaran RR; Altin ES and 4 more

Journal:
Curr Obes Rep

Publication Year: 2023

DOI:
10.1007/s13679-023-00510-7

PMCID:
PMC10220347

PMID:
37243875

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Curr Obes Rep

Abbreviation: Curr Obes Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Hypothalamic-Ovarian axis and Adiposity Relationship in Polycystic Ovary Syndrome: Physiopathology …
Lonardo MS; Cacciapuoti N; Guida B and 4 more (2024) - Transparency Score: 3/6
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications.
Guglielmi V; Bettini S; Sbraccia P and 6 more (2023) - Transparency Score: 3/6
Effects of Nutrition and Exercise Interventions on Persons with Sarcopenic Obesity: An Umbrella Rev…
Reiter L; Bauer S; Traxler M and 5 more (2023) - Transparency Score: 4/6
Ketogenic Diet: A Nutritional Therapeutic Tool for Lipedema?
Verde L; Camajani E; Annunziata G and 6 more (2023) - Transparency Score: 3/6
Ketogenic Diet as a Possible Non-pharmacological Therapy in Main Endocrine Diseases of the Female R…
Camajani E; Feraco A; Verde L and 6 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest The authors declare no conflict of interest."

Evidence found in paper:

"Funding The authors received no funding for this study or the preparation of the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025